LienTeh.net > Ads > ZEGFROVY (Sunvozertinib)

ZEGFROVY (Sunvozertinib)

Inquire / Price

Model Number：

RL3220250101
Brand Name：

ZEGFROVY®/舒沃哲®
Origin：

Original invention from China
Small Orders：

Small batches also available
Tags：

Lung Cancer

Details
Description

Packaging Size

7t*2blister/Box
Strength

150mg
Compositon

Sunvozertinib
Treatment

adult patients with locally advanced or metastatic NSCLC harboring EGFR exon 20 insertion mutations
Form

Tablet
Brand

ZEGFROVY®/舒沃哲®
Quantity Unit

14t/Box
Manufacturer

Dizal Pharma, china

Sunvozertinib (DZD9008) is an oral, potent, irreversible, and selective EGFR TKI targeting EGFR exon20ins as well as EGFR sensitizing, T790M, and uncommon mutations with weak activity against wild-type EGFR.

Sunvozertinib is being developed by Dizal Pharmaceuticals, a joint venture between AstraZeneca and the Chinese Future Industry Investment Fund.

Sunvozertinib sold under the brand name 舒沃哲® in china.
Sunvozertinib sold under the brand name ZEGFROVY® in USA.

In August 2023, China’s National Medical Products Administration approved sunvozertinib for the treatment of adult patients with locally advanced or metastatic NSCLC harboring EGFR exon 20 insertion mutations whose disease has progressed on or following platinum-based chemotherapy, based on data from the phase 2 WU-KONG6 trial (NCT05712902).